A phase Ib, double-blind, randomized, dose-cohort escalation study of intravenous PRO 140 [PRO-140] or placebo in adult patients with HIV-1 infection
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2008
At a glance
- Drugs Leronlimab (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Progenics Pharmaceuticals
- 03 Oct 2008 Results published in the Journal of Infectious Diseases in November 2008.
- 05 May 2008 Status change
- 15 Feb 2008 Added sponsor and investigator from Current Controlled Trials record.